Richard C. Young & Co’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23.2M Sell
19,363
-35
-0.2% -$35.8K 1.71% 21
2026
Q1
$17.8M Buy
19,398
+122
+0.6% +$124K 1.48% 33
2025
Q4
$20.7M Buy
19,276
+1,091
+6% +$1.04M 1.86% 17
2025
Q3
$13.9M Buy
+18,185
New +$13.5M 1.29% 36

Other funds holding LLY

Richard C. Young & Co's LLY Position: Q2 2026 in Review

Richard C. Young & Co reduced its Eli Lilly (LLY) stake by 0.18% in Q2 2026, selling an estimated $35.8K and leaving 19,363 shares worth $23.2M. The position accounts for 1.71% of the portfolio, ranked #21.

Richard C. Young & Co first reported a position in LLY in Q3 2025 and has held it in 4 quarters since. 1,899 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Richard C. Young & Co held 19,363 shares of Eli Lilly worth $23.2M as of Q2 2026.
  • Richard C. Young & Co sold 35 Eli Lilly shares in Q2 2026, an estimated $35.8K.
  • Eli Lilly made up 1.71% of Richard C. Young & Co's portfolio in Q2 2026, its #21 holding.
  • Richard C. Young & Co first reported a position in Eli Lilly in Q3 2025 and has held it in 4 quarters since.
  • 1,899 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Richard C. Young & Co's 13F filing for Q2 2026, filed 28 Jul 2026.